Duloxetine hydrochloride sustained release medicine

Duloxetine hydrochloride sustained-release drug, duloxetine hydrochloride by the oral medicament composed acceptable excipient ingredient, wherein duloxetine is 15% to 65% of the total weight of the pharmaceutical, said auxiliary component polymer skeleton comprising at least sustained-release materials, and the release rate modifying ingredient outer enteric coating material, polymer skeleton and a sustained release material 1% to 80%, the release rate modifying ingredient is from 0.1% to 50%, outer enteric the coating material is 1.5 to 10%. The drug has a Sustained Release Matrix erosion of intestinal function, rapid onset, high efficacy, prolonged action, a significant reduction in the amount of drug released after taking the instant adverse reactions, blood concentration and drug effect lasting more stable, enhancing patient medication compliance and clinical outcomes.